SLC35A1

CMP-sialic acid transporter · P78382 · SLC35A1 on Sugi Atlas →

0 patent compounds predicted against SLC35A1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC35A1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Age on the Renal Clearance of Adefovir PHASE4WITHDRAWN
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery PHASE4COMPLETED
Reformulated F75 Milk to Treat Severe Acute Malnutrition PHASE2/PHASE3COMPLETED
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1/PHASE2COMPLETED
[18F]MC225-PET in Neurodegenerative Disease PHASE1/PHASE2UNKNOWN
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases PHASE1COMPLETED
A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine PHASE1COMPLETED
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP) PHASE1COMPLETED
Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors PHASE1COMPLETED
Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuvastatin PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I EARLY_PHASE1COMPLETED
Choroid Plexus Dysfunction in Neurological Diseases nanRECRUITING
The Natural History of Sialidosis Type I nanRECRUITING
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Chest Wall Deformities in Children - Epidemiological Data nanCOMPLETED
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features nanUNKNOWN
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs nanCOMPLETED
Sialic Acid in Hepatocellular Carcinoma nanNOT_YET_RECRUITING
Fluorescence and Glioma Heterogeneity nanCOMPLETED
A Proof-of-concept Study Evaluating the Microbiota-gut-brain Axis nanRECRUITING
Collection of Tissue Samples for Study of Multidrug Resistance nanCOMPLETED
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers nanCOMPLETED
Impact of Genetics on Metformin Pharmacokinetics nanCOMPLETED
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management nanUNKNOWN
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION
Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients nanUNKNOWN
Characterization of Breg Cells nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC35A1 binder may also engage these)

ProteinNameSimilarity
O08520 1.000 O08520 →
Q61420 1.000 Q61420 →
O16658 0.991 O16658 →
P87041 0.989 P87041 →
Q6AXR5 0.982 Q6AXR5 →
Q02334 0.979 Q02334 →
Q9Y2D2 0.979 Q9Y2D2 →
Q93890 0.978 Q93890 →
Q8MII5 0.977 Q8MII5 →
Q8R1T4 0.977 Q8R1T4 →
Q66HX0 0.975 Q66HX0 →
Q6YC49 0.974 Q6YC49 →
Q18779 0.973 Q18779 →
O77592 0.973 O77592 →
Q6V7K3 0.973 Q6V7K3 →
Q8WMS0 0.972 Q8WMS0 →
P78383 0.972 P78383 →
Q58DA6 0.972 Q58DA6 →
Q8AWB6 0.971 Q8AWB6 →
P97858 0.971 P97858 →
P78381 0.971 P78381 →
Q9R0M8 0.971 Q9R0M8 →
Q9VDD7 0.969 Q9VDD7 →
Q95YI5 0.968 Q95YI5 →
Q8AXS6 0.968 Q8AXS6 →
Q7Z769 0.967 Q7Z769 →
A4IFK2 0.966 A4IFK2 →
Q6GQ70 0.966 Q6GQ70 →
Q9SUV2 0.965 Q9SUV2 →
Q9SKJ7 0.965 Q9SKJ7 →